Tongxin Yilian Technology
An online medical examination booking service platform base in Beijing,China
About Tongxin Yilian Technology
Tongxin Yilian Technology (Beijing) Co., Ltd., which has since evolved and rebranded to "Tongxin Zhìyī", represents a strategic pivot within the Chinese digital health landscape. The company was established in 2014 by Liu Weiqi, an alumnus of Stanford University and Shanghai Jiao Tong University. His background in medicine, investment, and management spurred the creation of the firm, which initially focused on leveraging the internet to enhance medical imaging services. The founding team was composed of individuals with backgrounds from Stanford University, Tsinghua University, and Peking University Health Science Center, possessing extensive experience in medical IT and hospital administration.
Originally, Tongxin Yilian operated as a medical health O2O service provider, offering tools for both doctors and patients. The business model centered on creating a medical imaging consortium, utilizing the internet to deliver third-party medical imaging operational services nationwide. This model aimed to expand access to high-quality imaging resources and facilitate a tiered system of diagnosis and treatment. The company's evolution saw a significant shift towards a more integrated approach, combining an online internet hospital with physical imaging centers and a cloud-based platform. This hybrid model serves a diverse client base including clinical physicians, patients with specific diseases, imaging centers, and AI imaging specialists. Revenue is generated through this multi-faceted service provision, which includes building internet platforms, managing medical services, and constructing physical imaging centers.
The company's service offerings have become increasingly sophisticated over time. After initially focusing on chronic disease management and follow-up, the company transitioned to a platform for sharing underutilized imaging resources, eventually investing in its own imaging centers to control data acquisition. A major strategic development was the integration of artificial intelligence, culminating in the brand upgrade to "Tongxin Zhìyī" and its positioning as a next-generation AI brain science diagnosis and treatment platform. This platform is built on three pillars: "Tongxin Brain Science" for medical technology R&D, "Tongxin Gewu" for AI product conversion, and the original "Tongxin Yilian" as the product application platform. The company has developed over 10 AI-driven products for brain science, such as intelligent analysis for aneurysms, with several receiving NMPA certification. This ecosystem creates a flywheel effect, where clinical application feeds data back for product iteration. By 2022, its services had reached over 500 imaging centers and medical institutions across 26 provinces in China.
Source: Dealroom company dataNews
Open roles
Tongxin Yilian Technology in the Dongcheng District ecosystem
The Tongxin Yilian Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- CCChina Merchants Capital
- BGBojiang Capital Management Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tongxin Yilian Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tongxin Yilian Technology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


